25
Power of Data & Supply Chain Ramgopal Cancherla 3 rd Annual Manufacturing Excellence Mumbai, INDIA April 2008

Cancherla manu tech_apr08

Embed Size (px)

DESCRIPTION

A peek into "The Power of Data" with specific ref to Supply-chain where lots of data is generated by the minute & Teams are busy fire -fighting every moment !!

Citation preview

Page 1: Cancherla manu tech_apr08

Power of Data&

Supply Chain

Ramgopal Cancherla3rd Annual Manufacturing Excellence

Mumbai, INDIAApril 2008

Page 2: Cancherla manu tech_apr08

Data Stewards

Database

Data Management

Data Mart

Data Bank

Data Inconsistencies

Data Mining

Data Warehouse

Data Processor

Data Security

Data Recovery

Top of the mind

Page 3: Cancherla manu tech_apr08

Topics Overview of Pharma Industry Overview of

Supply chain applications & interfaces

Data Perspectives & Viewpoints

Page 4: Cancherla manu tech_apr08

Other EUROPE

USA

Germany

Japan

Spain

ItalyUK

Russia

ITC

Canada

France

Asia-Pacif ic

Worldwide Pharmaceutical Market : 474 EUR Bn. in 2007

Region perimeter : SA Regions

Source : IMS / RMBC MAT Q4-07

USA200 EUR Bn.(42%)

Intercontinental27 EUR Bn. (6%)

Europe (incl. Canada)134 EUR Bn. (28%)

Asia-Pacific & Russia & Japan85 EUR Bn (18%)

Japan : 42 Bn (9%)

Russia : 6 Bn (1%)

Asia-Pacific : 37 Bn (8%)

Asia Pacific- Russia – Japan region : 18% of WW Sales in 2007

France29 EUR Bn. (6%)

Page 5: Cancherla manu tech_apr08

Worldwide Pharmaceutical Market : +6% growth vs. last year (value)

Region perimeter : SA Regions

Source : IMS / RMBC MAT Q4-07

Highest growth in Emerging markets.Asia-Pacific 8% of worldwide sales, 14% of worldwide growth

50% of Asia-Pacific growth came from China

+4.1% +4.2%

+6.5% +6.6%

+11.4%

+13.9%

+6.1%

+7.5%

+27,314+1,691+7,855 +1,747 +8,307 +392 +2,770

+4,552

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

14.0%

16.0%

18.0%

20.0%

USA JAPAN WORLD FRANCE EUROPE RUSSIA ITC ASIA-PACIFIC

0

5,000

10,000

15,000

20,000

25,000

30,000

Grth %

Grth ME

Page 6: Cancherla manu tech_apr08

Sanofi-aventis key figures

* Definition of consolidated sales and adjusted net income – p 21/22** Data at December 31, 2006

Sanofi-aventis, a leading global pharmaceutical company, discovers,

develops and distributes therapeutic solutions to improve the lives of

everyone.

Sanofi-aventis key figures …• Consolidated sales 2006 * : 28.4 billion euros• Adjusted net income in 2006 * : 7 billion euros (+11.1%)• R&D budget : 4.4 billion euros (+9.5%)• 100,000 employees ** present in nearly 100 Countries

Page 7: Cancherla manu tech_apr08

A remarkable medicines portfolio

Central Nervous System

Cardiometabolism

Thrombosis

Oncology

Internal medicine

Page 8: Cancherla manu tech_apr08

Suppliers

Manufacturers

Distributors

Retailers

CustomersConsumersThey keep us in Business

Page 9: Cancherla manu tech_apr08

Supply chain Applications & Interfaces

Forecasting & Demand Planning - Manugisitcs

ERP – SAP DW – Cognos LRP - Intranet Applications Microsoft Excel

Page 10: Cancherla manu tech_apr08

Supply chain Applications & Interfaces

ERP ERP

Forecasting & PlanningSales Heads

Demand

Fulfillment

Sales History (Shipments) Statistical Forecast

Total Sales Forecast

Causal Factors & Events

Total Sales Forecast+= For Local MTS products

Inventory on hand

Independent DemandMRP Calculation

Vehicle Loads (In Transits)

Scheduled Receipts

Inventory on hand

Vehicle Loads (In Transits)

Scheduled Receipts

Planned Orders=

---

Net DemandFor Locally manufactured products

For Local MTO products

Intranet Tool Intranet ToolOrders Planned ArrivalsOr =

Orders

For imported products from Europe

Page 11: Cancherla manu tech_apr08

Today’s Situation of Data Existence Plethora of business applications Technology of interfaces Various formats

Page 12: Cancherla manu tech_apr08

How Did We Get Here?

Improve productivity thru’ easier access

Eliminate duplicate efforts Prevent poor decisions based on

faulty information Support to Business [cost

avoidance, cost reduction, quality approach, investor confidence]

Page 13: Cancherla manu tech_apr08

MastersFoundation of all Applications

TransactionsPurpose of Applications & Business

DataGenerated thru Ongoing Transactions

Page 15: Cancherla manu tech_apr08

InformationStructured Data

InterpretationUsage of Structured Data – Evaluation of NEEDS

DecisionEnables Achievement of Immediate, Medium & Long Term Goals

Page 16: Cancherla manu tech_apr08

Power of Data

Page 17: Cancherla manu tech_apr08
Page 18: Cancherla manu tech_apr08

“ Instead of concentrating only on workmen productivity, it is high time that managers & executives concentrate on what they can do by a process of introspection on their role as change agents.”

THE HINDU SPEAKS ON MANAGEMENT

Page 19: Cancherla manu tech_apr08

Shift the focus : a Viewpoint

People Involvement& Management

40%

Business Process Knowledge

30%

Product Knowledge

20%

InfrastructureManagement

10%

Page 20: Cancherla manu tech_apr08

Paradigm Shift : a viewpoint Independent to Interdependent Functional Excellence to Functional

Integration Internal Competition to

Collaboration Shared vision to excel over

Competition in the Global Market place

Page 21: Cancherla manu tech_apr08

Please Do Not…. : a viewpoint

Under estimate the workload Under estimate the stress Discriminate between sources Under estimate the costs

Page 22: Cancherla manu tech_apr08

7 6 5 4 3 2 1 0

Total Delivery Time

Total

Costs

Subtly balance costs & service levels

Q1

20%

Q2

40%

Q3

60%

Q4

80%

Q5

100%

Page 23: Cancherla manu tech_apr08
Page 24: Cancherla manu tech_apr08

INDIA HEALTH INFRASTRUCTURE - 2006

Doctors Nurses Hospitals Hospital Beds PHC Medical Colleges Chemists Medical Reps

6,25,131 8,36,000 17,300 9,14,543 1,63,196 171 5,00,000 3,00,000

Page 25: Cancherla manu tech_apr08

Power to OUR data in the spirit of

CUSTOMER SERVICE !!

Thank U